Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablat… Read more
Adagio Medical Holdings, Inc Common Stock (ADGM) - Total Assets
Latest total assets as of September 2025: $31.55 Million USD
Based on the latest financial reports, Adagio Medical Holdings, Inc Common Stock (ADGM) holds total assets worth $31.55 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Adagio Medical Holdings, Inc Common Stock - Total Assets Trend (2020–2024)
This chart illustrates how Adagio Medical Holdings, Inc Common Stock’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Adagio Medical Holdings, Inc Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
Adagio Medical Holdings, Inc Common Stock's total assets of $31.55 Million consist of 52.3% current assets and 47.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 42.5% |
| Accounts Receivable | $35.00K | 0.1% |
| Inventory | $2.57 Million | 5.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $6.97 Million | 14.4% |
| Goodwill | $13.97 Million | 28.8% |
Asset Composition Trend (2020–2024)
This chart illustrates how Adagio Medical Holdings, Inc Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Adagio Medical Holdings, Inc Common Stock's current assets represent 52.3% of total assets in 2024, an increase from 4.1% in 2020.
- Cash Position: Cash and equivalents constituted 42.5% of total assets in 2024, up from 0.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 28.8% of total assets.
Adagio Medical Holdings, Inc Common Stock Competitors by Total Assets
Key competitors of Adagio Medical Holdings, Inc Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Adagio Medical Holdings, Inc Common Stock - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Adagio Medical Holdings, Inc Common Stock generates 0.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Adagio Medical Holdings, Inc Common Stock is currently not profitable relative to its asset base.
Adagio Medical Holdings, Inc Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.84 | 4.42 | 0.52 |
| Quick Ratio | 0.68 | 3.90 | 0.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.56 Million | $ 27.11 Million | $ -6.24 Million |
Adagio Medical Holdings, Inc Common Stock - Advanced Valuation Insights
This section examines the relationship between Adagio Medical Holdings, Inc Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.88 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | 609.9% |
| Total Assets | $48.45 Million |
| Market Capitalization | $4.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values Adagio Medical Holdings, Inc Common Stock's assets below their book value (0.08 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Adagio Medical Holdings, Inc Common Stock's assets grew by 609.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Adagio Medical Holdings, Inc Common Stock (2020–2024)
The table below shows the annual total assets of Adagio Medical Holdings, Inc Common Stock from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $48.45 Million | +609.86% |
| 2023-12-31 | $6.83 Million | -21.52% |
| 2022-12-31 | $8.70 Million | -59.44% |
| 2021-12-31 | $21.44 Million | +50409.95% |
| 2020-12-31 | $42.45K | -- |